NICE rejects AstraZeneca’s breast cancer drug
December 14, 2011Sales and Marketing AstraZeneca, Faslodex, NICE
NICE has made its final decision not to recommended AstraZeneca’s breast cancer drug Faslodex, as it says the drug is …
NICE gives partial recommendation for RoActemra
December 14, 2011Sales and Marketing RoActemra, Roche
Roche’s patient access scheme has persuaded NICE to recommend RoActemra in childhood arthritis under certain circumstances. In its final guidance …
New cancer drug costs escalating for NHS
December 13, 2011Cancer, NHS, oncology
New oncology drugs are pushing up the overall costs of treating cancer, according to a new report. The ‘Cancer Diagnosis …
GSK’s Stiefel accused of shares fraud
December 13, 2011Sales and Marketing GSK, SEC, Stiefel, fraud
The US financial regulator has charged a subsidiary of GlaxoSmithKline with defrauding staff by buying back shares from them at …
Ian Read elected as chairman of the board at Pfizer
December 13, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Kindler, Pfizer
Pfizer’s chief executive and president Ian Read has been elected as the firm’s new chairman. Read succeeds George Lorch as …
Abbott signs $400 million deal with Reata
December 13, 2011Research and Development, Sales and Marketing Abbott
Abbott has signed a new deal with inflammatory specialist Reata for its portfolio of early-stage compounds. Abbott and Reata Pharmaceuticals …
Pfizer awaits verdict on contaminated site clean-up plan
December 13, 2011Manufacturing and Production, Sales and Marketing FDA, Pfizer, manufacturing
The US Environmental Protection Agency is due to deliver a verdict on a $205 million proposal by Pfizer to clean …
Katherine Baicker elected to Lilly’s board of directors
December 12, 2011Business Services, Research and Development, Sales and Marketing lilly
Lilly has elected Katherine Baicker as a new member of its board of directors, effective immediately. Baicker, 40, is Professor …
New report highlights postcode lottery for medicines
December 12, 2011DoH, NHS, UK
A new report by the Department of Health illustrates a stark postcode lottery in drug spend for patients with chronic …
GSK’s Tyverb fails late-stage trial in breast cancer
December 12, 2011Research and Development, Sales and Marketing GSK, Tyverb, breast cancer
GlaxoSmithKline’s Tyverb has failed to help women with HER2 positive breast cancer increase their survival. The TEACH study’s primary objective …
Who’s really in charge of the new NHS?
December 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS reform
Each year the health service, the Department of Health and the UK pharmaceutical industry get an opportunity to say what …
EMA and FDA move closer on inspections
December 12, 2011Manufacturing and Production EMA, FDA
The EMA and US FDA has taken a step closer to mutual recognition of manufacturing site inspections, launching a three-year …
Janssen inks $150m deal for blood cancer drug
December 12, 2011Research and Development, Sales and Marketing Janssen, Pharmacyclics
Janssen biotech has signed a licensing deal with Pharmacyclics for its investigational blood cancer drug. The firm has paid $150 …
SHL receives great response at the 2011 PDA in Basel
December 12, 2011Manufacturing and Production autoinjector, pda, pen injector, prefilled syringe, shl group
SHL successfully wrapped up this year’s exhibition at the PDA’s ” The Universe of Pre-filled Syringes and Injection Devices” 2011 …
Takeda’s blood pressure treatment Edarbi approved
December 9, 2011Sales and Marketing Diovan, Eisai, cardiovascular, high blood pressure, hypertension
Takeda’s new hypertension treatment Edarbi has been approved in Europe.Edarbi (azilsartan medoxomil) is a new once-daily angiotensin receptor blocker (ARB) …
Succinct Communications makes three appointments
December 9, 2011Business Services, Medical Communications, Sales and Marketing Succinct
Succinct Communications has appointment a number of new staff members to support the growth of its organisation. Chris Stevenson joins …
Dechra Pharmaceuticals PLC FDA Approval for manufacturing at Dales Pharmaceuticals
December 9, 2011Manufacturing and Production, Research and Development FDA Approval
Dechra® Pharmaceuticals PLCFDA APPROVAL FOR MANUFACTURING AT DALES® PHARMACEUTICALS Dales Pharmaceuticals (‘Dales’ or the ‘Company’), based in Skipton, North Yorkshire, UK, …
Erectile dysfunction drugs restricted on NHS
December 9, 2011Sales and Marketing Cialis, ED, Levitra, NHS, PCTs, viagra
Health authorities in England are restricting the use of erectile dysfunction drugs to help cut costs. Pfizer’s Viagra, Lilly’s Cialis …
Novartis warned over standards at generics sites
December 9, 2011Manufacturing and Production CGMP Failures, FDA compliance, Novartis, Sandoz
The FDA has warned Novartis that three North American production facilities operated by its generics subsidiary Sandoz are failing to …
Dr Rajeev Venkayya to head Takeda’s new vaccine business
December 9, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda
Takeda will establish a new vaccine business division in January next year and will appoint Dr Rajeev Venkayya as its …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
